🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

12 recruiting trials

for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection NCT06746883n/a12 sites📍 Sacramento📍 Gainesville📍 Tampa Innoviva Specialty Therapeutics · Tests: Non-interventional Impact of BioFire FilmArray Pneumonia Panel vs Routine Diagnostics on Antimicrobial Outcomes (DOOR-MAT) NCT07585604NA1 site📍 Porto Alegre Hospital de Clinicas de Porto Alegre · Tests: Multiplex PCR-based pneumonia panel (BIOFIRE® FILMARRAY® Pneumonia Panel) A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection NCT06801223Phase 14 sites📍 Los Angeles📍 San Diego📍 Greenville Innoviva Specialty Therapeutics · Tests: Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours), Sulbacta… Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria NCT07512596Phase 227 sites📍 Bengbu📍 Beijing📍 Chongqing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: TQD3524, Meropenem for injection, Colistimethate Sodium for Injection A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex NCT06087536Phase 215 sites📍 Athens📍 Athens📍 Athens Omnix Medical Ltd · Tests: OMN6, Placebo Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections NCT07089186Phase 31 site📍 Shanghai Qilu Pharmaceutical Co., Ltd. · Tests: Meropenem and Pralurbactam, Best Available Therapy (e.g., colistin, meropenem, tegecycline, amikacinceftezidime-avibata… Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation NCT05405491NA1 site📍 Lille University Hospital, Lille · Tests: PCR based strategy, Standard care NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia NCT07759934Phase 21 site📍 Nanjing Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Tests: ASK0912 for Injection, ASK0912 for Injection, Polymyxin B Sulfate for Injection A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP NCT07327619Phase 31 site📍 Huaihua Qilu Pharmaceutical Co., Ltd. · Tests: Meropenem and Pralurbactam, Ceftazidime-avibactam Optimising TREATment for Severe Gram-Negative Bacterial Infections NCT07004049Phase 441 sites📍 Brisbane📍 Brisbane📍 Hangzhou National University of Singapore · Tests: Colistin/Polymyxin B + Sulbactam, Colistin/Polymyxin B + Tigecycline/Eravacycline, Colistin/Polymyxin B + Meropenem, Ce… Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex NCT07326540Phase 31 site📍 Tbilisi BioVersys SAS · Tests: BV100 (300 mg), Polymyxin B, Colistin, Ampicillin-Sulbactam, MEROPENEM 2 grams TID
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy